Home
Live Updates
FDA Extends Review Time for Investigational Duchenne Agent Givinostat : comparemela.com
FDA Extends Review Time for Investigational Duchenne Agent Givinostat
Givinostat, a histone deacetylase inhibitor from Italfarmaco, was supported by data from the phase 3 EPIDYS study, a randomized, double-blind, placebo-controlled, multicenter trial investigating the agent vs placebo.
Related Keywords
Paolo Bettica ,
Italfarmaco Paolo Bettica ,
Craig Mcdonald ,
Department Of Pediatrics ,
Uc Davis Health ,
Uc Davis Health Craig Mcdonald ,
Prescription Drug User Fee Act ,
North Star Ambulatory Assessment ,
Physical Medicine ,
Epidys ,
Italfarmaco ,
Givinostat ,
Admd ,
Histone Deacetylase ,
comparemela.com © 2020. All Rights Reserved.